Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Test-Retest Variability of Quick Contrast Sensitivity Function Testing
Status: Enrolling
Updated:  4/10/2017
Nova Southeastern University; College of Optometry
mi
from
Fort Lauderdale, FL
Test-Retest Variability of Quick Contrast Sensitivity Function Testing
Status: Enrolling
Updated: 4/10/2017
Nova Southeastern University; College of Optometry
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
A Phase 1, Pilot, Single-Dose, 4-Way Crossover Study to Compare the Pharmacokinetics of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
Status: Enrolling
Updated:  4/10/2017
Celerion
mi
from
Tempe, AZ
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
A Phase 1, Pilot, Single-Dose, 4-Way Crossover Study to Compare the Pharmacokinetics of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production
Status: Enrolling
Updated: 4/10/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
Status: Enrolling
Updated:  4/10/2017
Celerion
mi
from
Tempe, AZ
Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production
Status: Enrolling
Updated: 4/10/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
The Effects of Aging and Estrogen on the Pituitary
The Effect of Aging on the Isolated Pituitary Response to Gonadotropin Releasing Hormone at Baseline and With Low Dose Estrogen Administration
Status: Enrolling
Updated:  4/12/2017
Massachusetts General Hospital
mi
from
Boston, MA
The Effects of Aging and Estrogen on the Pituitary
The Effect of Aging on the Isolated Pituitary Response to Gonadotropin Releasing Hormone at Baseline and With Low Dose Estrogen Administration
Status: Enrolling
Updated: 4/12/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)
A Study in Healthy Subjects to Assess the Effect of Intragastric pH and Fasting on the Multiple-Dose Pharmacokinetics of AF-219
Status: Enrolling
Updated:  4/17/2017
Celerion
mi
from
Tempe, AZ
A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)
A Study in Healthy Subjects to Assess the Effect of Intragastric pH and Fasting on the Multiple-Dose Pharmacokinetics of AF-219
Status: Enrolling
Updated: 4/17/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations
A Study in Healthy Subjects to Assess the Multiple-Dose Pharmacokinetics of Two AF-219 Formulations
Status: Enrolling
Updated:  4/17/2017
Celerion
mi
from
Tempe, AZ
A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations
A Study in Healthy Subjects to Assess the Multiple-Dose Pharmacokinetics of Two AF-219 Formulations
Status: Enrolling
Updated: 4/17/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations
A Study in Healthy Subjects to Assess the Multiple- Dose Pharmacokinetics of Three AF-219 Formulations
Status: Enrolling
Updated:  4/17/2017
Celerion
mi
from
Tempe, AZ
A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations
A Study in Healthy Subjects to Assess the Multiple- Dose Pharmacokinetics of Three AF-219 Formulations
Status: Enrolling
Updated: 4/17/2017
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
A Double-Blind, Placebo-Controlled, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
Status: Enrolling
Updated:  4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
A Double-Blind, Placebo-Controlled, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
Status: Enrolling
Updated: 4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Click here to add this to my saved trials
Brain Areas Involved in Sound and Spoken Word Memory
The Role of the Inferior Frontal Gyrus in Long-Term Auditory Memory a rTMS Study
Status: Enrolling
Updated:  4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Brain Areas Involved in Sound and Spoken Word Memory
The Role of the Inferior Frontal Gyrus in Long-Term Auditory Memory a rTMS Study
Status: Enrolling
Updated: 4/19/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
UW Psilocybin Pharmacokinetics Study
Pharmacokinetics of Psilocybin in Normal Adult Volunteers
Status: Enrolling
Updated:  4/19/2017
University of Wisconsin, School of Pharmacy
mi
from
Madison, WI
UW Psilocybin Pharmacokinetics Study
Pharmacokinetics of Psilocybin in Normal Adult Volunteers
Status: Enrolling
Updated: 4/19/2017
University of Wisconsin, School of Pharmacy
mi
from
Madison, WI
Click here to add this to my saved trials
Noninvasive Study of Brain Connectivity With EEG and NIRS
Non-Invasive Study of Brain Connectivity Using Combined EEG and NIRS
Status: Enrolling
Updated:  4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Noninvasive Study of Brain Connectivity With EEG and NIRS
Non-Invasive Study of Brain Connectivity Using Combined EEG and NIRS
Status: Enrolling
Updated: 4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
A Randomized, Placebo Controlled, Phase1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
Status: Enrolling
Updated:  4/24/2017
University of Michigan
mi
from
Ann Arbor, MI
Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
A Randomized, Placebo Controlled, Phase1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
Status: Enrolling
Updated: 4/24/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
A Phase 1, Open-Label Study to Evaluate the Pharmacodynamics, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
Status: Enrolling
Updated:  4/24/2017
Celerion
mi
from
Lincoln, NE
A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
A Phase 1, Open-Label Study to Evaluate the Pharmacodynamics, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
Status: Enrolling
Updated: 4/24/2017
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
Vietnam Era Health Retrospective Observational Study
Vietnam Era Health Retrospective Observational Study
Status: Enrolling
Updated:  4/24/2017
U.S. Department of Veterans Affairs/Epidemiology Program
mi
from
Washington, D.C.,
Vietnam Era Health Retrospective Observational Study
Vietnam Era Health Retrospective Observational Study
Status: Enrolling
Updated: 4/24/2017
U.S. Department of Veterans Affairs/Epidemiology Program
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Fun For Wellness: Online Well-Being Promotion Intervention in a Patient Sample
Fun For Wellness Online Intervention to Promote Multidimensional Well-Being: A Randomized Controlled Trial in a Community-Based Patient Sample
Status: Enrolling
Updated:  4/24/2017
UHealth Lennar Medical Center
mi
from
Miami, FL
Fun For Wellness: Online Well-Being Promotion Intervention in a Patient Sample
Fun For Wellness Online Intervention to Promote Multidimensional Well-Being: A Randomized Controlled Trial in a Community-Based Patient Sample
Status: Enrolling
Updated: 4/24/2017
UHealth Lennar Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor
Status: Enrolling
Updated:  4/27/2017
Masimo Clinical Lab
mi
from
Irvine, CA
Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor
Status: Enrolling
Updated: 4/27/2017
Masimo Clinical Lab
mi
from
Irvine, CA
Click here to add this to my saved trials
Accuracy of Noninvasive Rainbow Adhesive R2-25 Pulse Oximeter Sensor
Status: Enrolling
Updated:  4/27/2017
Masimo Clinical Lab
mi
from
Irvine, CA
Accuracy of Noninvasive Rainbow Adhesive R2-25 Pulse Oximeter Sensor
Status: Enrolling
Updated: 4/27/2017
Masimo Clinical Lab
mi
from
Irvine, CA
Click here to add this to my saved trials
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
Status: Enrolling
Updated:  5/1/2017
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
Status: Enrolling
Updated: 5/1/2017
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
Status: Enrolling
Updated:  5/1/2017
Baltimore Washington Medical Center
mi
from
Glen Burnie, MD
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
Status: Enrolling
Updated: 5/1/2017
Baltimore Washington Medical Center
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Time to Conceive: A Study of Fertility
Time to Conceive: A Study of Fertility: Biomarkers of Fertility
Status: Enrolling
Updated:  5/3/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Time to Conceive: A Study of Fertility
Time to Conceive: A Study of Fertility: Biomarkers of Fertility
Status: Enrolling
Updated: 5/3/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Assess The Safety, Tolerability, And Pharmacokinetics With 2-weeks Of Dosing Of Pf-06427878 In Overweight-obese, Otherwise Healthy Adult Subjects
Status: Enrolling
Updated:  5/3/2017
California Clinical Trials Medical Group
mi
from
Glendale, CA
A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Assess The Safety, Tolerability, And Pharmacokinetics With 2-weeks Of Dosing Of Pf-06427878 In Overweight-obese, Otherwise Healthy Adult Subjects
Status: Enrolling
Updated: 5/3/2017
California Clinical Trials Medical Group
mi
from
Glendale, CA
Click here to add this to my saved trials
A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Assess The Safety, Tolerability, And Pharmacokinetics With 2-weeks Of Dosing Of Pf-06427878 In Overweight-obese, Otherwise Healthy Adult Subjects
Status: Enrolling
Updated:  5/3/2017
Qps-Mra, Llc
mi
from
South Miami, FL
A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Assess The Safety, Tolerability, And Pharmacokinetics With 2-weeks Of Dosing Of Pf-06427878 In Overweight-obese, Otherwise Healthy Adult Subjects
Status: Enrolling
Updated: 5/3/2017
Qps-Mra, Llc
mi
from
South Miami, FL
Click here to add this to my saved trials
MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics
Magnetic Resonance Cholangiopancreatography (MRCP): A Reliable, Non Invasive Method for Staging Chronic Pancreatitis From Minimal Change Disease to the Advanced Stages in Pediatrics
Status: Enrolling
Updated:  5/3/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics
Magnetic Resonance Cholangiopancreatography (MRCP): A Reliable, Non Invasive Method for Staging Chronic Pancreatitis From Minimal Change Disease to the Advanced Stages in Pediatrics
Status: Enrolling
Updated: 5/3/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Impact of Fatigue on Jumping Performance
Impact of Fatigue on Jumping Performance
Status: Enrolling
Updated:  5/3/2017
Creighton University
mi
from
Omaha, NE
Impact of Fatigue on Jumping Performance
Impact of Fatigue on Jumping Performance
Status: Enrolling
Updated: 5/3/2017
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects
An Open-Label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects
Status: Enrolling
Updated:  5/9/2017
Clinical Research Facility
mi
from
Madison, WI
A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects
An Open-Label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects
Status: Enrolling
Updated: 5/9/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals
A Single-dose, Open-label, Fixed Sequence, Two Period Cross Over Study to Assess the Tolerability of a Supra Therapeutic Dose of TRV130 Followed by A Single Dose, Randomized, Double Blind, Comparative, Positive and Placebo Controlled, Four Period Cross-over Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on the QTc Intervals in Healthy Subjects
Status: Enrolling
Updated:  5/11/2017
Clinical Research Facility
mi
from
Baltimore, MD
Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals
A Single-dose, Open-label, Fixed Sequence, Two Period Cross Over Study to Assess the Tolerability of a Supra Therapeutic Dose of TRV130 Followed by A Single Dose, Randomized, Double Blind, Comparative, Positive and Placebo Controlled, Four Period Cross-over Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on the QTc Intervals in Healthy Subjects
Status: Enrolling
Updated: 5/11/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of RO7079901 Administered Intravenously Both Alone and in Combination With Meropenem in Adult Healthy Volunteers
Status: Enrolling
Updated:  5/18/2017
Covance Clinical Research Unit Inc.; Covance Gfi Research
mi
from
Evansville, IN
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of RO7079901 Administered Intravenously Both Alone and in Combination With Meropenem in Adult Healthy Volunteers
Status: Enrolling
Updated: 5/18/2017
Covance Clinical Research Unit Inc.; Covance Gfi Research
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of RO7079901 Administered Intravenously Both Alone and in Combination With Meropenem in Adult Healthy Volunteers
Status: Enrolling
Updated:  5/18/2017
Covance Clinical Research Unit
mi
from
Madison, WI
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of RO7079901 Administered Intravenously Both Alone and in Combination With Meropenem in Adult Healthy Volunteers
Status: Enrolling
Updated: 5/18/2017
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
A Phase 1a Randomized, Blinded, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI9314 in Healthy Adult Subjects
Status: Enrolling
Updated:  5/30/2017
Clinical Research Facility
mi
from
Glendale, CA
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
A Phase 1a Randomized, Blinded, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI9314 in Healthy Adult Subjects
Status: Enrolling
Updated: 5/30/2017
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
A Phase 1a Randomized, Blinded, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI9314 in Healthy Adult Subjects
Status: Enrolling
Updated:  5/30/2017
Research Site
mi
from
Harrow,
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
A Phase 1a Randomized, Blinded, Placebo-controlled, Single-ascending Dose Study to Evaluate the Safety and Tolerability of MEDI9314 in Healthy Adult Subjects
Status: Enrolling
Updated: 5/30/2017
Research Site
mi
from
Harrow,
Click here to add this to my saved trials
Metabolic Flexibility as a Biomarker of Adaptation to Diet and Exercise Challenges
Status: Enrolling
Updated:  5/30/2017
USDA Beltsville Human Nutrition Center
mi
from
Beltsville, MD
Metabolic Flexibility as a Biomarker of Adaptation to Diet and Exercise Challenges
Status: Enrolling
Updated: 5/30/2017
USDA Beltsville Human Nutrition Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets
Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets
Status: Enrolling
Updated:  6/5/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets
Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets
Status: Enrolling
Updated: 6/5/2017
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants
A Phase 1, Open-label, Sequential Study to Investigate the Pharmacokinetic Interaction Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Subjects
Status: Enrolling
Updated:  6/7/2017
Clinical Research Facility
mi
from
Tempe, AZ
A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants
A Phase 1, Open-label, Sequential Study to Investigate the Pharmacokinetic Interaction Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
DSM265 Prophylaxis of Plasmodium Falciparum Malaria
Proof-of-concept, Single Center Study in Healthy Adult Volunteers to Investigate Safety, Tolerability, Pharmacokinetics and Prophylactic Activity of Single Dose DSM265 in a Controlled Human Malarial Infection Challenge Either by Direct Venous Inoculation of Plasmodium Falciparum Sporozoites or Mosquito-borne Plasmodium Falciparum
Status: Enrolling
Updated:  6/13/2017
Fred Hutchinson Cancer Research Center - Prevention Center
mi
from
Seattle, WA
DSM265 Prophylaxis of Plasmodium Falciparum Malaria
Proof-of-concept, Single Center Study in Healthy Adult Volunteers to Investigate Safety, Tolerability, Pharmacokinetics and Prophylactic Activity of Single Dose DSM265 in a Controlled Human Malarial Infection Challenge Either by Direct Venous Inoculation of Plasmodium Falciparum Sporozoites or Mosquito-borne Plasmodium Falciparum
Status: Enrolling
Updated: 6/13/2017
Fred Hutchinson Cancer Research Center - Prevention Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
A Phase 1, Randomized, Open-Label, Replicate, Crossover Study to Assess the Bioequivalence of Lesinurad/Allopurinol Fixed-Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets in Fed Healthy Adult Subjects
Status: Enrolling
Updated:  6/15/2017
Clinical Research Facility
mi
from
Austin, TX
Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
A Phase 1, Randomized, Open-Label, Replicate, Crossover Study to Assess the Bioequivalence of Lesinurad/Allopurinol Fixed-Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets in Fed Healthy Adult Subjects
Status: Enrolling
Updated: 6/15/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin
Effect of LY3314814 on the Pharmacokinetics of Rosuvastatin in Caucasian Healthy Subjects
Status: Enrolling
Updated:  6/19/2017
Covance Clinical Research Inc
mi
from
Daytona Beach, FL
A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin
Effect of LY3314814 on the Pharmacokinetics of Rosuvastatin in Caucasian Healthy Subjects
Status: Enrolling
Updated: 6/19/2017
Covance Clinical Research Inc
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
TMS Modulation of Insula-related Brain Networks
TMS Modulation of Insula-related Brain Networks
Status: Enrolling
Updated:  6/19/2017
Duke University
mi
from
Durham, NC
TMS Modulation of Insula-related Brain Networks
TMS Modulation of Insula-related Brain Networks
Status: Enrolling
Updated: 6/19/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Depotentiation in People With Focal Hand Dystonia
Depotentiation in Focal Hand Dystonia Patients
Status: Enrolling
Updated:  6/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Depotentiation in People With Focal Hand Dystonia
Depotentiation in Focal Hand Dystonia Patients
Status: Enrolling
Updated: 6/21/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of LY3337641 in Japanese and Caucasian Healthy Participants
A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3337641 in Japanese and Caucasian Healthy Subjects
Status: Enrolling
Updated:  6/21/2017
Wcct Global, Llc
mi
from
Cypress, CA
A Study of LY3337641 in Japanese and Caucasian Healthy Participants
A Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3337641 in Japanese and Caucasian Healthy Subjects
Status: Enrolling
Updated: 6/21/2017
Wcct Global, Llc
mi
from
Cypress, CA
Click here to add this to my saved trials
A First-in-Human Study of BNZ132-1-40
A First-in-human Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of BNZ132-1-40
Status: Enrolling
Updated:  6/21/2017
Celerion
mi
from
Phoenix, AZ
A First-in-Human Study of BNZ132-1-40
A First-in-human Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of BNZ132-1-40
Status: Enrolling
Updated: 6/21/2017
Celerion
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Metabolism and Excretion of [14C]-Rigosertib After Infusion to Volunteers
Phase I Study of the Metabolism and Excretion of [14C]-Rigosertib After Single-dose Administration as 24-hour Continuous Intravenous Infusion to Healthy Volunteers
Status: Enrolling
Updated:  6/22/2017
Covance Clinical Research Unit
mi
from
Madison, WI
Metabolism and Excretion of [14C]-Rigosertib After Infusion to Volunteers
Phase I Study of the Metabolism and Excretion of [14C]-Rigosertib After Single-dose Administration as 24-hour Continuous Intravenous Infusion to Healthy Volunteers
Status: Enrolling
Updated: 6/22/2017
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants
Randomized, Open-Label, 2-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Subjects
Status: Enrolling
Updated:  6/22/2017
Celerion
mi
from
Lincoln, NE
A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants
Randomized, Open-Label, 2-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Subjects
Status: Enrolling
Updated: 6/22/2017
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers
A Phase 1 Safety, Pharmacokinetic, and Immunologic Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers
Status: Enrolling
Updated:  6/26/2017
Rockefeller University
mi
from
New York, NY
A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers
A Phase 1 Safety, Pharmacokinetic, and Immunologic Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers
Status: Enrolling
Updated: 6/26/2017
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Drug-Drug Interaction Study of AG120 in Healthy Subjects
An Open-Label, 2-Period, Fixed Sequence Study to Determine the Effect of Multiple Oral Doses of Itraconazole on the Single Dose Pharmacokinetics of AG 120 in Healthy Adult Subjects
Status: Enrolling
Updated:  6/26/2017
Clinical Research Facility
mi
from
Tempe, AZ
Drug-Drug Interaction Study of AG120 in Healthy Subjects
An Open-Label, 2-Period, Fixed Sequence Study to Determine the Effect of Multiple Oral Doses of Itraconazole on the Single Dose Pharmacokinetics of AG 120 in Healthy Adult Subjects
Status: Enrolling
Updated: 6/26/2017
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
Status: Enrolling
Updated:  6/26/2017
Celerion
mi
from
Lincoln, NE
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
Status: Enrolling
Updated: 6/26/2017
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/28/2017
Miami Research Associates
mi
from
South Miami, FL
A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/28/2017
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  6/28/2017
mi
from
Singapore,
A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 6/28/2017
mi
from
Singapore,
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Burbank, CA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Burbank, CA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Temecula, CA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials